Table 3 Perioperative outcome: resection for non-small cell lung cancer vs resection for other pathologies
From: Lung resection surgery in Jehovah’s Witness patients: a 20-year single-center experience
NSCLC | Other pathology | |
|---|---|---|
Operations (patients) | 9 (7) | 8 (7) |
Reoperation | 2 | 1 |
Anatomic resection | 6 | 3 |
Wedge resection | 3 | 5 |
VATS as initial approach (%) | 8 (88%) | 6 (75%) |
Conversion to thoracotomy (%) | 4 (50%) | 0 (0%) |
Operative mortality (%) | 1 (11%) | 0 (0%) |
Overall survival at 6 months (%) | 8/9 (88.8%) | 8/8 (100%) |
EBL median (IQR) | 188 (106, 1188) | 40 (8, 88) |
Hemoglobin decrease median (gm/dL; IQR) | 1.5 (− 0.1, 2.1) | 1.1 (0.5, 2.2) |
LOS median (days; IQR) | 2 (2, 3) | 1.5 (1, 3) |
Chest tube duration median (days; IQR) | 2 (2, 3) | 1 (1, 2) |